Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy
Sight Sciences, Inc. Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $4.54
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS